Doliver Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Doliver Advisors's PFE Position: Q3 2023 in Review
Doliver Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,934 shares — an estimated $218K sold.
Doliver Advisors first reported a position in PFE in Q3 2018 and held it in 17 quarters. The position peaked at $703K in Q3 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Doliver Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Doliver Advisors sold 5,934 Pfizer shares in Q3 2023, an estimated $218K.
- Doliver Advisors first reported a position in Pfizer in Q3 2018 and held it in 17 quarters.
- Doliver Advisors's Pfizer position peaked at $703K in Q3 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Doliver Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.